Bellone Stefania, Shah Hemendrah R, McKenney Jesse K, Stone Pamela J B, Santin Alessandro D
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology Yale University School of Medicine, New Haven, CT 06520-8063, USA.
Am J Obstet Gynecol. 2008 Sep;199(3):e7-e10. doi: 10.1016/j.ajog.2008.04.012. Epub 2008 Jun 12.
Recurrent/metastatic endometrial adenocarcinoma that is not amenable to cure with local or regional therapy and/or chemotherapy represents a discouraging clinical entity for the clinician. We report the case of 58-year-old woman with recurrent endometrial carcinoma that was resistant to chemotherapy that was treated successfully with the aromatase inhibitor anastrozole.
无法通过局部或区域治疗和/或化疗治愈的复发性/转移性子宫内膜腺癌,对于临床医生而言是一个令人沮丧的临床情况。我们报告了一例58岁复发性子宫内膜癌女性患者,该患者对化疗耐药,但使用芳香化酶抑制剂阿那曲唑成功治愈。